Subscribe to Newsletter

Advanced Medicine

Manufacture Advanced Medicine

Introducing a Regulatory Playbook for Gene Therapy

| Stephanie Vine

In this video interview, Courtney Silverthorn explains the inspiration behind a free regulatory playbook for gene therapy manufacturers.

Business & Regulation Standards & Regulation

FDA Warning Letters: April 2024 Edition

| Stephanie Vine | 6 min read

Production records written using erasable markers, use of expired raw materials, and more.

Manufacture Advanced Medicine

Interviewing Luigi Naldini: Be a Little Different

| Stephanie Vine | 8 min read

How the drive to try something new led to the development of lentiviral vectors for gene therapy.

Manufacture Advanced Medicine

Cell and Gene Therapies: Live at Phacilitate with Delara Motlagh, Head of Global Cell Therapy, Catalent

Discussing the trends in cell and gene therapeutics, with Delara Motlagh, Head of Global Cell Therapy, Catalent

Manufacture Advanced Medicine

Cell and Gene Therapies: Live at Phacilitate with George Eastwood, Board Member, Emily Whitehead Foundation

Discussing the trends in cell and gene therapeutics, with George Eastwood, Board Member, Emily Whitehead Foundation

Manufacture Advanced Medicine

Cell and Gene Therapies: Live at Phacilitate with Stella Vnook, CEO, Likarda

Discussing the trends in cell and gene therapeutics, with Stella Vnook, CEO, Likarda

Manufacture Advanced Medicine

Cell and Gene Therapies: Live at Phacilitate with Joel Eichmann, CEO, Green Elephant

Discussing the trends in cell and gene therapeutics, with Joel Eichmann, CEO, Green Elephant, live at Phacilitate

Discovery & Development Drug Discovery

Hunting for a Cure

| Jamie Irvine | 5 min read

The world’s first clinical trial for a Hunter syndrome gene therapy opens in Manchester

Business & Regulation Profession

Let’s Talk About Talent

| Stephanie Vine | 12 min read

We speak with Vertex Pharmaceuticals about internships and co-ops in the industry for young talent.

Manufacture Advanced Medicine

Getting Gene Therapy into the Fast Lane

| George Buchman | 8 min read

Gene therapy approvals have come thick and fast in 2023. Now let’s talk about how we can ramp up manufacturing speed with platform processes.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register